Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhizoma sparganii (San Leng, 三棱) is the dried rhizome of Sparganium stoloniferum Buch.-Ham., widely used in Traditional Chinese Medicine (TCM). It is primarily indicated for gynecological conditions such as dysmenorrhea (painful menstruation), amenorrhea due to blood stasis, abdominal masses and distension. In TCM theory it "breaks up blood stasis," "moves Qi," relieves pain and dissolves accumulations. Modern pharmacological studies have identified approximately 180 compounds in rhizoma sparganii—including phenylpropanoids, flavonoids, anthraquinones and volatile oils—with reported activities such as anti-tumor, antithrombotic (blood clot prevention), estrogen antagonistic effects (anti-estrogenic), anti-inflammatory and analgesic properties. It also has demonstrated reproductive toxicity and should not be used during pregnancy[5][1][8]. The herb is typically administered orally as a decoction or granule extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rhizoma sparganii.